Skip to main content
. 2021 Feb 22;15(2):e0009103. doi: 10.1371/journal.pntd.0009103

Fig 2. Survival rate in the 23 SFTS patients who received favipiravir.

Fig 2

Overall survival rate in the 23 SFTS patients who received favipiravir is shown based on the survival time plotted using the Kaplan-Meier method (A). Survival probabilities of patients with higher SFTSV viremia level (≥ 1 × 105 copies/mL, dotted line, n = 10) and that of patients with lower SFTSV viremia level (< 1 × 105 copies/mL, solid line, n = 13) are shown (B).